What Is Nitroglycerin Used For? A Comprehensive Guide

Nitroglycerin is a medication primarily known for its ability to relieve chest pain associated with angina. This guide dives deep into the uses of nitroglycerin, exploring its approved applications, off-label uses, mechanism of action, administration methods, potential side effects, and crucial safety information. Whether you’re a healthcare professional or a patient seeking to understand this medication better, this comprehensive overview will provide you with valuable insights.

Approved and Off-Label Uses of Nitroglycerin

Nitroglycerin is a well-established vasodilator, meaning it widens blood vessels. It was first introduced as a treatment for angina in 1879 and has been a cornerstone in managing anginal chest pain ever since.

FDA-Approved Uses:

• Acute Relief of Angina: Nitroglycerin is primarily used to quickly alleviate chest pain (angina pectoris) caused by reduced blood flow to the heart due to coronary artery disease.
• Acute Prophylaxis of Angina: It can also be used preventatively before activities likely to trigger angina, such as exercise or emotional stress.

Off-Label Uses (Non-FDA Approved):

While nitroglycerin is most recognized for treating angina, it also finds applications in treating other conditions under the guidance of a healthcare professional. These “off-label” uses include:

• Hypertensive Urgency/Emergency: Nitroglycerin can help rapidly lower severely high blood pressure in urgent or emergency situations.
• Coronary Artery Spasm: It can relieve spasms in the coronary arteries, which can cause chest pain.
• Angina Secondary to Cocaine Use: Nitroglycerin can help manage chest pain induced by cocaine use.
• Congestive Heart Failure (CHF): In some cases, nitroglycerin can alleviate symptoms of heart failure by reducing the workload on the heart.
• Chronic Anal Fissures: Topical nitroglycerin ointment can promote healing and relieve pain associated with chronic anal fissures by increasing blood flow to the area and relaxing the anal sphincter.
• Heart Failure with Reduced Ejection Fraction (HFrEF): Nitroglycerin, combined with hydralazine, is used in patients with HFrEF who cannot take ACE inhibitors.
• Radial Artery Spasm During Coronary Angiography: Nitroglycerin helps prevent spasms in the radial artery when it is used to access the heart during angiography.

How Nitroglycerin Works: Mechanism of Action Explained

Nitroglycerin’s primary effect stems from its conversion to nitric oxide (NO) within the body. Nitric oxide is a potent vasodilator. Here’s a breakdown of the process:

1. Conversion to Nitric Oxide (NO): Nitroglycerin is metabolized into nitric oxide.
2. Activation of Guanylyl Cyclase: NO activates an enzyme called guanylyl cyclase.
3. cGMP Production: Guanylyl cyclase converts guanosine triphosphate (GTP) to guanosine 3′,5′-cyclic monophosphate (cGMP).
4. Smooth Muscle Relaxation: cGMP triggers a cascade of events leading to the dephosphorylation of myosin light chains within smooth muscle cells. This causes the smooth muscle in blood vessel walls to relax.
5. Vasodilation: The relaxation of smooth muscle leads to vasodilation, widening of blood vessels.

The primary desired effect of nitroglycerin is venodilation, leading to reduced preload, decreased cardiac workload and reduced anginal symptoms.

Nitroglycerin Administration: Routes and Dosage

Nitroglycerin is available in several forms, each with its own administration method and purpose.

• Sublingual Tablets: These are the most common form for acute angina relief. The tablet is placed under the tongue and allowed to dissolve, allowing for rapid absorption into the bloodstream. Available dosages include 0.3 mg, 0.4 mg, and 0.6 mg. The dose can be repeated every 5 minutes for a maximum of three doses. If chest pain persists after three doses, immediate medical attention is necessary.
• Intravenous (IV) Administration: Used in hospitals, particularly in emergency rooms and intensive care units, when sublingual nitroglycerin is ineffective or when rapid and continuous relief is needed. It’s frequently used in acute coronary syndromes, hypertensive emergencies, and acute heart failure exacerbations. Intravenous nitroglycerin requires careful monitoring of vital signs.
• Transdermal Ointment: A 2% ointment applied to the skin, typically used when sublingual administration isn’t feasible or tolerated. Absorption takes approximately 5-10 minutes. Avoid applying repeatedly to the same area to prevent skin irritation.
• Transdermal Patches: These deliver a continuous dose of nitroglycerin over a prolonged period and are primarily used for angina prophylaxis.

Nitroglycerin Side Effects: What to Expect

Like all medications, nitroglycerin can cause side effects. Most side effects are related to its vasodilatory effects.

Common side effects include:

• Dizziness
• Weakness
• Palpitations
• Vertigo
• Headaches (can be severe and throbbing)
• Nausea
• Vomiting
• Diaphoresis (sweating)
• Syncope (fainting)

Orthostatic hypotension, a drop in blood pressure upon standing, is also a common side effect, leading to dizziness and lightheadedness. In individuals who are preload dependent, profound hypotension can occur.

Nitroglycerin Contraindications: When to Avoid

Nitroglycerin is not suitable for everyone. It’s crucial to be aware of the contraindications:

• Allergy: Known allergy to nitroglycerin or other nitrates.
• Increased Intracranial Pressure: History of increased pressure inside the skull.
• Severe Anemia: Significantly low red blood cell count.
• Right-Sided Myocardial Infarction: Heart attack affecting the right ventricle.
• PDE-5 Inhibitors: Concurrent use of phosphodiesterase-5 (PDE-5) inhibitors like sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra) due to the risk of severe hypotension and syncope.

Monitoring Nitroglycerin Therapy

Due to its short half-life and rapid metabolism, routine blood tests to measure nitroglycerin levels are not typically performed. However, close monitoring is essential, especially during intravenous administration.

• Intravenous Nitroglycerin: Requires continuous blood pressure monitoring, heart rate monitoring, respiratory rate monitoring, and oxygen saturation monitoring.
• Sublingual Nitroglycerin: Effectiveness is primarily assessed by the resolution of symptoms like angina, hypertension, and heart failure.

Before prescribing, providers should review the patient’s medication list to check for potential interactions. Limit alcohol intake while taking nitroglycerin. Nitroglycerin is pregnancy category C, and breastfeeding mothers should use it with caution.

Nitroglycerin Overdose and Toxicity

Overdose from nitroglycerin primarily results in excessive vasodilation and hypotension. Symptoms can include:

• Hypotension
• Tachycardia (rapid heart rate)
• Palpitations
• Headache
• Confusion
• Vertigo
• Nausea
• Vomiting
• Visual Disturbances

Severe overdose can lead to increased intracranial pressure, dyspnea (difficulty breathing), heart block, bradycardia (slow heart rate), paralysis, seizures, coma, and death.

Treatment focuses on increasing central fluid volume with intravenous normal saline and elevating the patient’s legs. Vasoconstricting agents like epinephrine are generally not recommended. In rare cases, methemoglobinemia (a condition where the blood cannot carry oxygen effectively) can occur. Methylene blue can be administered intravenously to treat methemoglobinemia.

A Team Approach to Nitroglycerin Use

Effective and safe use of nitroglycerin requires a collaborative effort from clinicians, cardiology specialists, primary care providers, pharmacists, and nurses. Everyone involved in a patient’s care should understand the indications, contraindications, potential adverse effects, and drug interactions associated with nitroglycerin. Pharmacists play a crucial role in monitoring for drug interactions. This interprofessional collaboration ensures optimal patient outcomes and minimizes the risk of adverse events.

References

1. Parratt JR. Nitroglycerin–the first one hundred years: new facts about an old drug. J Pharm Pharmacol. 1979 Dec;31(12):801-9.
2. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3203-7.
3. Thadani U, Lipicky RJ. Short and long-acting oral nitrates for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug;8(4):611-23.
4. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation. 1981 Dec;64(6):1089-97.
5. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol. 2000 Sep;184(3):409-20.
6. Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci. 2015 Oct;129(2):83-94.
7. Webb RC. Smooth muscle contraction and relaxation. Adv Physiol Educ. 2003 Dec;27(1-4):201-6.
8. Boden WE, Padala SK, Cabral KP, Buschmann IR, Sidhu MS. Role of short-acting nitroglycerin in the management of ischemic heart disease. Drug Des Devel Ther. 2015;9:4793-805.
9. Holt DB, Pang PS. Vasodilator Therapies in the Treatment of Acute Heart Failure. Curr Heart Fail Rep. 2019 Feb;16(1):32-37.
10. Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm. 2009 Aug 01;66(15):1343-52.
11. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP, Kuntz RE, Baim DS. Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention. Circulation. 1994 Jun;89(6):2514-8.
12. Todd PA, Goa KL, Langtry HD. Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use. Drugs. 1990 Dec;40(6):880-902.
13. Taylor SH. The role of transdermal nitroglycerin in the treatment of coronary heart disease. Am Heart J. 1986 Jul;112(1):197-207.
14. Divakaran S, Loscalzo J. The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics. J Am Coll Cardiol. 2017 Nov 07;70(19):2393-2410.
15. Drugs and Lactation Database (LactMed®) [Internet]. National Institute of Child Health and Human Development; Bethesda (MD): Oct 15, 2024. Nitroglycerin.
16. Kloner RA. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions. Am J Cardiol. 2005 Dec 26;96(12B):42M-46M.
17. Ferguson JJ, Diver DJ, Boldt M, Pasternak RC. Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction. Am J Cardiol. 1989 Aug 01;64(5):311-4.
18. Ramey JT, Lockey RF. Allergic and nonallergic reactions to nitroglycerin. Allergy Asthma Proc. 2006 May-Jun;27(3):273-80.
19. Ishikura F, Beppu S, Hamada T, Khandheria BK, Seward JB, Nehra A. Effects of sildenafil citrate (Viagra) combined with nitrate on the heart. Circulation. 2000 Nov 14;102(20):2516-21.
20. Bosson N, Isakson B, Morgan JA, Kaji AH, Uner A, Hurley K, Henry TD, Niemann JT. Safety and Effectiveness of Field Nitroglycerin in Patients with Suspected ST Elevation Myocardial Infarction. Prehosp Emerg Care. 2019 Sep-Oct;23(5):603-611.
21. Long B, Koyfman A, Gottlieb M. Management of Heart Failure in the Emergency Department Setting: An Evidence-Based Review of the Literature. J Emerg Med. 2018 Nov;55(5):635-646.
22. Ghani GA, Sung YF, Weinstein MS, Tindall GT, Fleischer AS. Effects of intravenous nitroglycerin on the intracranial pressure and volume pressure response. J Neurosurg. 1983 Apr;58(4):562-5.
23. Buenger JW, Mauro VF. Organic nitrate-induced methemoglobinemia. DICP. 1989 Apr;23(4):283-8.